KRAS-targeted therapies in cancer: novel approaches and overcoming resistance bmjoncology.bmj.com/content/4/1/...

Excited to be at #esmo! Though there is so much on the agenda I don't know where to begin - suggestions are welcome! @myesmo.bsky.social

✅ Highlights the urgent need for equity & global trial harmonization. ❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities? #OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch bmjoncology.bmj.com/content/4/1/...

Really excited to see this paper live on BMJ Oncology! The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬 bmjoncology.bmj.com/content/4/1/... #radiation #kidneycancer #oncology

Really excited to see this paper live on BMJ Oncology! The authors have provided a comprehensive overview of the tumour-infiltrating lymphocyte therapy landscape, and their work will be a valuable resource for the field 🔬 bmjoncology.bmj.com/content/4/1/... #immunotherapy #immunology #oncology

We're hiring a new clinical editor to join our team and support the launch of a new journal, BMJ Surgery Clinical Editor - BMJ Surgery £69,632 (pro-rata 0.4fte) London, Hybrid jobsearch.bmj.com/jobs/latest If you want to know more email [email protected]

Significant gaps in testing for #lynchsyndrome #hereditarycancer risk, UK study finds @bmj.com #cancerresearch #oncsky #openaccess

Can targeted therapies towards the hypoxia-inducible factor (HIF) pathway enhance the potency of current cancer treatments? This review explores the science: bmjoncology.bmj.com/content/3/1/... #cancer #hypoxia #oncology

New pub on cancer accelerated approvals in which we find: 1) PMR statements often lack specificity on key study design elements and 2) less stringent specs in PMR statements are associated with on-time submission, potentially trading rigor for speed. bmjoncology.bmj.com/content/4/1/...

I'm wondering if I can get some help with the kind people of @bsky.app. I'm trying to compile a list of key conferences across the broad field of #immunology - if you have any thoughts please reply or directly message. All suggestions welcome!👍

BMJ Oncology features research from OUCH members Dr. Roselle De Guzman & Dr. Joan Schiller on how pollutants contribute to cancer incidence and outcomes. Cleaner air isn't just an environmental issue; it's a public health necessity. Read more: bmjoncology.bmj.com/content/4/1/... #CancerResearch

Innovations in #clinical #education - great opportunity to listen to ways to maximise learning for students across #healthcare #crtitical #thinking and #creative #arts. Don’t miss it 👇 @radchat.bsky.social @journal-kristoffer.bsky.social @yattsang.bsky.social @gerryhanna.bsky.social

Happy PM day to all who celebrate! PubMed, that is. BMJ Oncology is proud to announce that all our content is now available on PubMed! 🎉 🍾 🥂 @journal-kristoffer.bsky.social @mazer.us @eabhalynn.bsky.social @oncoalert.bsky.social

A study by Zhao et al. showed that since 1990, the incidence and deaths of early onset cancers have substantially increased globally🌍🌏🌍 Countries with a high-middle and middle Sociodemographic Index and individuals aged 40–49 years were particularly affected bmjoncology.bmj.com/content/2/1/...

I think this is great! If you want @bsky.app to continue to grow then give the big publishing bodies an excuse to back this app - share research and click on research. #research #oncology

This is a true testament to how I think this platform differs - I don't know this account, but just check out how wholesome it is as a concept 🥰 I look forward to following, committing to reading the book and inevitably letting everyone down 😅 @oncologybookclub.bsky.social @bsky.app

Flash backs to university when my friends who left their dissertation write-up and submission to the final minute and did better than me 😆

📣 Check out this recent study: UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/... #cancer #chemotherapy

We are working on a whole new set of courses on #palliativecare for BMJ Learning, starting with this one on pain management. If you want to know more, please contact: @journal-kristoffer.bsky.social

I clicked through into this special issue and nearly every article drew me in, such an interesting array of work. Give it a click this Friday afternoon and treat yourself to a bit of insight! 💻📱 Well done to all involved 👏

Are we overlooking cancer's hidden toxicities? 🧠Mental health strain 💰 Financial burdens ⏳ Logistical chaos Should addressing these be as routine as managing the tumor itself? #Oncology #CancerCare Check out this paper by BMJ ONC's patient advocate Rick Bangs: bmjoncology.bmj.com/content/3/1/...

Clinical endpoints (eg survival) measure real outcomes, but surrogate endpoints (eg tumor shrinkage) often fall short of predicting outcomes Can misuse of surrogates in trials harm patients? Are we too reliant on surrogates? bmjoncology.bmj.com/content/3/1/... @vinayprasadmdmph.bsky.social #Oncology

Couldn't agree more!👏 The joy of not having to scroll past adverts, promoted content and boosted profiles on x! I'm excited to dive deeper and connect with those excited about sharing their ideas, work and enthusiasm!

Hi everyone! 👋 I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com). I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺